Capital International Sarl Dexcom Inc Transaction History

Capital International Sarl

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $286,236 - $333,344	2,545 Added 13.71%	21,107 $2.71 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $216,424 - $255,796	2,081 Added 12.63%	18,562 $2.16 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $231,995 - $334,889	2,730 Added 19.85%	16,481 $1.87 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $47,566 - $58,674	623 Added 4.75%	13,751 $1.11 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $721,033 - $1.41 Million	10,605 Added 420.33%	13,128 $978,000
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $188,065 - $260,269	1,999 Added 381.49%	2,523 $1.29 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $68,051 - $85,317	524 New	524 $281,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

Stay updated on Capital International Sarl with notifications on news.